var title_f39_23_40304="Stage II lateral condyle fracture";
var content_f39_23_40304=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Stage II fracture of the lateral condyle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) Anteroposterior radiograph shows 4 mm of displacement of the metaphyseal segment; however, the fracture was stable by stress examination and arthrography. Panel B) Four weeks after percutaneous pinning, the fracture is healed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 5th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2001.&nbsp;Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40304=[""].join("\n");
var outline_f39_23_40304=null;
var title_f39_23_40305="Propiverine: International drug information";
var content_f39_23_40305=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Propiverine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4369745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Detrunorm (GB);",
"     </li>",
"     <li>",
"      Mictonetten (DE);",
"     </li>",
"     <li>",
"      Mictonorm (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F2638211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Propiverine Hel",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2638212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticholinergic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F2638213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of urinary frequency, urgency, and incontinence in neurogenic bladder disorders in idiopathic detrusor instability",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F2638215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: Usual dosage: 15 mg 2-3 times/day; may increase dose to 4 times/day, some patients may respond to 15 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2638216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 15 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10478 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-CCB85E928E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40305=[""].join("\n");
var outline_f39_23_40305=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4369745\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638211\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638212\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638213\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638215\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821143\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638216\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10478\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10478|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_23_40306="Butoconazole: Drug information";
var content_f39_23_40306=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Butoconazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/56/34691?source=see_link\">",
"    see \"Butoconazole: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Gynazole-1&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F143807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Femstat&reg; One;",
"     </li>",
"     <li>",
"      Gynazole-1&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F143823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Vaginal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F143809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vulvovaginal candidiasis: Intravaginal:",
"     <i>",
"      Gynazole-1&reg;:",
"     </i>",
"     Insert 1 applicatorful (&sim;5 g) intravaginally as a single dose; treatment may need to be extended for up to 6 days in pregnant women (use in pregnancy during 2nd or 3rd trimester only)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F143810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F143791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, vaginal, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gynazole-1&reg;: 2% (5 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F143778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F143792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local treatment of vulvovaginal candidiasis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F143821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain or cramping",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Pelvic pain; vulvar/vaginal burning, itching, soreness, and swelling",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F143796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to butoconazole or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F143782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation: If irritation or sensitization occurs, discontinue use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Petrolatum-based: Contains mineral oil which may weaken latex or rubber products (condoms, vaginal contraceptive diaphragms); do not use these products within 72 hours of treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; OTC product: Not for use in women with a first-time vaginal yeast infection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; HIV infection consideration: HIV infection should be considered in sexually-active women with difficult to eradicate recurrent vaginal yeast infections.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F143786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F143788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F143799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Butoconazole may be considered for the treatment of vulvovaginal candidiasis in pregnant women (CDC, 2010). Use may weaken rubber or latex condoms or diaphragms; separate use by 3 days.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F143811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16265712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if butoconazole is excreted in breast milk. The manufacturer recommends that caution be exercised when administering butoconazole to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Gynazole-1 Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2% (5.8 g): $90.00",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F143800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Femstat One (CA);",
"     </li>",
"     <li>",
"      Gynazole-1 (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F143781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits biosynthesis of ergosterol, damaging the fungal cell wall membrane, which increases permeability in susceptible fungi (",
"     <i>",
"      Candida",
"     </i>",
"     ), causing leaking of nutrients",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F143795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: 2%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 12-24 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40306/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9178 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-81EFD22CC2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40306=[""].join("\n");
var outline_f39_23_40306=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143806\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143807\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143823\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143809\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143810\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143791\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143778\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143792\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143821\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143796\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143782\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298917\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143786\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143788\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143799\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143811\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16265712\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570477\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143800\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143781\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143795\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9178\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9178|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/56/34691?source=related_link\">",
"      Butoconazole: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_23_40307="Trimethoprim and polymyxin B: Patient drug information";
var content_f39_23_40307=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Trimethoprim and polymyxin B: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/19/5429?source=see_link\">",
"     see \"Trimethoprim and polymyxin B: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/5/38996?source=see_link\">",
"     see \"Trimethoprim and polymyxin B: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F231539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Polytrim&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F231540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      PMS-Polytrimethoprim;",
"     </li>",
"     <li>",
"      Polytrim&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691501",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat eye infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to benzalkonium chloride, trimethoprim, polymyxin B, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014071\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11452 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-3AAB480B33-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40307=[""].join("\n");
var outline_f39_23_40307=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231539\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231540\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014062\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014061\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014066\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014067\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014069\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014064\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014065\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014070\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014071\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?5/19/5429?source=related_link\">",
"      Trimethoprim and polymyxin B: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/5/38996?source=related_link\">",
"      Trimethoprim and polymyxin B: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_23_40308="Normal upper airway MRI";
var content_f39_23_40308=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mid-sagittal MRI in a normal subject highlighting the four upper airway regions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 344px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Nasopharynx which is defined from the nasal turbinates to the hard palate; B) retropalatal (RP) oropharynx extending from the hard palate to the caudal margin of the soft palate, C) retroglossal (RG) region from the caudal margin of the soft palate to the base of the epiglottis; and D) hypopharynx which is defined from the base of the tongue to the larynx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard J Schwab, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40308=[""].join("\n");
var outline_f39_23_40308=null;
var title_f39_23_40309="Peritoneum colon rectum";
var content_f39_23_40309=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Idealized representation of the peritoneal and mesenteric relationships at various levels of the colon and rectum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 494px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Both the transverse and sigmoid colon are located intraperitoneally; at these levels, the visceral peritoneum forms a complete covering over the exterior of the bowel (the serosa), which is continuous with the mesentery (transverse and sigmoid mesocolon). In contrast, the ascending and descending colon lie within the lateral peritoneal cavity with their posterior and lateral surfaces in the retroperitoneum. At these levels, the visceral peritoneum is only present anteriorly and medially; there is no true mesentery, since the developing mesentery has fused to the posterior parietal peritoneum. The upper portion of the rectum lies above the peritoneal reflection. The anterior surface is covered by peritoneum (which forms the rectovesical pouch in men and the rectouterine pouch in women); there is no serosa over its posterior surface. The lower rectum lies beneath the peritoneum, and has no serosal layer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40309=[""].join("\n");
var outline_f39_23_40309=null;
var title_f39_23_40310="Cefotaxime: Pediatric drug information";
var content_f39_23_40310=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefotaxime: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=see_link\">",
"    see \"Cefotaxime: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/61/34771?source=see_link\">",
"    see \"Cefotaxime: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Claforan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F147494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cefotaxime Sodium For Injection;",
"     </li>",
"     <li>",
"      Claforan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1045979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Cephalosporin (Third Generation)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      General dosing, susceptible infection:",
"     </b>",
"     I.M., I.V. (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Body weight &lt;1 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &le;14 days: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA 15-28 days: 50 mg/kg/dose every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Body weight 1-2 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &le;7 days: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA 8-28 days: 50 mg/kg/dose  every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Body weight &gt;2 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &le;7 days: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA 8-28 days: 50 mg/kg/dose every 8 hours; in some cases, every 6 hours dosing has been used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infection, disseminated or scalp abscess:",
"     </b>",
"     I.M., I.V.: 25 mg/kg/dose every 12 hours for 7 days; therapy should be extended to 10-14 days if meningitis is documented (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Meningitis (Tunkel, 2004):",
"     </b>",
"     I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treat for a minimum of 21 days; use smaller doses and longer intervals for neonates &lt;2 kg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     PNA &le;7 days and &ge;2 kg: 100-150 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     PNA &gt;7days and &ge;2 kg: 150-200 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1045972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=see_link\">",
"      see \"Cefotaxime: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      General dosing, susceptible infection:",
"     </b>",
"     Infants, Children and Adolescents: I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     AAP recommendations (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Mild to moderate infection: 50-180 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     in divided doses every 6-8 hours; maximum daily dose: 6",
"     <b>",
"      g/day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Severe infection: 200-225 mg/kg/day in divided doses every 4-6 hours; up to 300 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     has been used for meningitis; maximum daily dose: 12",
"     <b>",
"      g/day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     &lt;50 kg: 50-180 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     &ge;50 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Uncomplicated infections: I.M., I.V.: 1000 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Moderate to severe infections: I.M., I.V.: 1000-2000 mg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Life-threatening infections: I.V.: 2000 mg every 4 hours, maximum daily dose: 12",
"     <b>",
"      g/day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis, severe infection requiring hospitalization:",
"     </b>",
"     Children and Adolescents: I.V.: 100-200 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 6 hours for 10-14 days; maximum dose: 2000 mg (Chow, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Community-acquired pneumonia (CAP)",
"     </b>",
"     (Bradley, 2011): Infants &gt;3 months, Children, and Adolescents: I.V.: 50 mg/kg/dose every 8 hours; maximum dose: 2000 mg;",
"     <b>",
"      Note:",
"     </b>",
"     May consider addition of vancomycin or clindamycin to empiric therapy if community-acquired MRSA suspected. In children &ge;5 years, a macrolide antibiotic should be added if atypical pneumonia cannot be ruled out.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Gonorrhea",
"     </b>",
"     (CDC, 2010, CDC, 2012): Children and Adolescents &ge;45 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Uncomplicated gonorrhea of the cervix, urethra, or rectum: I.M.: 500 mg as a single dose in combination with oral azithromycin or oral doxycycline",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Disseminated: I.V.: 1 g every 8 hours for a total duration of at least 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Intra-abdominal infection, complicated:",
"     </b>",
"     Infants, Children, and Adolescents: I.V.: 150-200 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 6-8 hours; maximum dose: 2000 mg; use in combination with metronidazole (Solomkin, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Lyme disease, cardiac or CNS manifestations or recurrent arthritis:",
"     </b>",
"     Infants, Children, and Adolescents: I.V.: 150-200 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     in divided doses every 6-8 hours for 14-28 days; maximum daily dose: 6",
"     <b>",
"      g/day",
"     </b>",
"     (Halperin, 2007; Wormser, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Meningitis:",
"     </b>",
"     Infants, Children, and Adolescents: I.V.: 225-300 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 6-8 hours; maximum dose: 2000 mg; use in combination with vancomycin for empiric coverage (Tunkel, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Peritonitis (CAPD)",
"     </b>",
"     (Warady, 2000): Infants, Children, and Adolescents: Intraperitoneal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Intermittent: 30 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Continuous: Loading dose: 500 mg per liter of dialysate; maintenance dose: 250 mg per liter;",
"     <b>",
"      Note:",
"     </b>",
"     125 mg/liter has also been recommended as a maintenance dose (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     I.M., I.V.: 1000-2000 mg every 4-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Uncomplicated infections: I.M., I.V.: 1000 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Moderate to severe infections: I.M., I.V.: 1000-2000 mg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Life-threatening infections: I.V.: 2000 mg every 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Caesarean section:",
"     </b>",
"     I.M., I.V.: 1000 mg as soon as the umbilical cord is clamped, then 1000 mg at 6- and 12-hour intervals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Gonorrhea",
"     </b>",
"     (CDC, 2010):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Uncomplicated gonorrhea of the cervix, urethra, or rectum: I.M.: 500 mg as a single dose in combination with oral azithromycin or oral doxycycline; may also administer 1000 mg as a single dose for rectal gonorrhea in males (per manufacturer labeling)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Disseminated: I.V.: 1000 mg every 8 hours for a total duration of at least 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Sepsis:",
"     </b>",
"     I.V.: 2000 mg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants, Children, and Adolescents: The following the adjustments have been recommended (Aronoff, 2007).",
"     <b>",
"      Note:",
"     </b>",
"     Renally adjusted dose recommendations are based on doses of 100-200 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     divided every 8 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     GFR 30-50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     GFR 10-29 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     GFR &lt;10 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Intermittent hemodialysis: 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Peritoneal dialysis (PD): 35-70 mg/kg/dose every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Continuous renal replacement therapy (CRRT): 35-70 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer&rsquo;s labeling:",
"     <b>",
"      Note:",
"     </b>",
"     Renal function may be estimated using Cockcroft-Gault formula for dosage adjustment purposes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Dose should be decreased by 50%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Alternate Dosing: The following dosage adjustments have been recommended:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     GFR &gt;50 mL/minute: Administer every 6 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     GFR 10-50 mL/minute: Administer every 6-12 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     GFR &lt;10 mL/minute: Administer every 24 hours",
"     <b>",
"      or",
"     </b>",
"     decrease the dose by 50% (and administer at usual intervals) (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Intermittent hemodialysis (IHD): 1-2 g every 24 hours (on dialysis days, administer after hemodialysis).",
"     <b>",
"      Note:",
"     </b>",
"     Dosing dependent on the assumption of 3 times/week, complete IHD sessions (Heintz, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Peritoneal dialysis (PD): 1 g every 24 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Continuous renal replacement therapy (CRRT) (Heintz, 2009; Trotman, 2005): Drug clearance is highly dependent on the method of renal replacement, filter type, and flow rate. Appropriate dosing requires close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, as well as drug concentrations in relation to target trough (if appropriate). The following are general recommendations only (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     CVVH:  1-2 g every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     CVVHD: 1-2 g every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     CVVHDF: 1-2 g every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Claforan&reg;: 1 g (50 mL); 2 g (50 mL) [contains sodium ~50.5 mg (2.2 mEq) per cefotaxime 1 g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 500 mg, 1 g, 2 g, 10 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Claforan&reg;: 500 mg, 1 g, 2 g, 10 g [contains sodium ~50.5 mg (2.2 mEq) per cefotaxime 1 g]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Powder",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1045982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: May be administered I.V. push over 3-5 minutes at a maximum concentration of 200 mg/mL or as an  intermittent I.V. infusion over 15-30 minutes at a final concentration of 20-60 mg/mL; avoid rapid injection (&lt; 1 minute) due to association with arrhythmias",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Reconstitute powder for injection with SWI to a final concentration between 230-330 mg/mL (see manufacturer labeling for specific details). Administer by deep I.M. injection into a large muscle mass such as the upper outer quadrant of the gluteus maximus. Doses of 2000 mg  should be divided and administered at two different sites.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F147547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in peritoneal dialysis solutions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, alprostadil, amifostine, aztreonam, bivalirudin, caffeine citrate, cyclophosphamide, cyclosporine, dexmedetomidine, diltiazem, docetaxel, etoposide phosphate, famotidine, fenoldopam, fentanyl, fludarabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydromorphone, levofloxacin, lorazepam, magnesium sulfate, melphalan, meperidine, milrinone, morphine, ondansetron, oxytocin, propofol, remifentanil, sargramostim, teniposide, thiotepa, tigecycline, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, azithromycin, filgrastim, fluconazole, gemcitabine, hetastarch in NS, pantoprazole, pemetrexed, pentamidine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Anakinra, cisatracurium, midazolam, vancomycin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Caffeine citrate, dimenhydrinate, heparin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Doxapram, pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1045976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for injection: Store intact vial at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light and high temperatures. Reconstituted solution is stable for 12-24 hours at room temperature, 7-10 days when refrigerated and for 13 weeks when frozen; duration is dependent upon concentration; see manufacturer&rsquo;s labeling for specific information. Upon further dilution with NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W for I.V. infusion, solution is stable for 24 hours at room temperature, 5 days when refrigerated, or 13 weeks when frozen in Viaflex&reg; plastic containers.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Premixed solution (manufacturer premixed): Store at -20&deg;C (-4&deg;F); once thawed, solutions are stable for 24 hours at room temperature or for 10 days refrigerated. Do not refreeze.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1045981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible lower respiratory tract, skin and skin structure, bone and joint, intra-abdominal, genitourinary tract, and gynecologic infections, bactermia/septicemia and documented or suspected central nervous system infections (eg, meningitis, ventriculitis) (FDA approved in all ages); prevention of postoperative surgical site infection in contaminated or potentially contaminated surgical procedures [eg, gastrointestinal and  genitourinary tract surgeries and hysterectomy (abdominal or vaginal)] and caesarian section (FDA approved in all ages)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F147549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cefotaxime may be confused with cefOXitin, cefuroxime",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Spectrocef [Italy] may be confused with Spectracef brand name for cefditoren [U.S., Great Britain, Mexico, Portugal, Spain]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F147546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Colitis, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain at injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Agranulocytosis, alkaline phosphatase increased, ALT increased, anaphylaxis, arrhythmia (after rapid I.V. injection via central catheter), AST increased, bilirubin increased, BUN increased, candidiasis, cholestasis, Coombs test (direct) positive, creatinine increased, encephalopathy, eosinophilia, erythema multiforme, fever, GGT increased, headache, hemolytic anemia, hepatitis, interstitial nephritis, jaundice, LDH increased, leukopenia, moniliasis, neutropenia, phlebitis, pseudomembranous colitis, Stevens-Johnson syndrome, thrombocytopenia, toxic epidermal necrolysis, transaminases increased, urticaria, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Aplastic anemia, hemorrhage, pancytopenia, renal dysfunction, seizure, superinfection, toxic nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1045985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cefotaxime, any component, or cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1045971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with impaired renal function. Granulocytopenia and more rarely agranulocytosis may develop during prolonged treatment (&gt;10 days).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1045970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment; use with caution in patients with a history of colitis. May cause hypersensitivity reaction; patients with history of hypersensitivity reactions to other cephalosporins or pencillins may experience cross-sensitivity; use with caution in patients with a history of penicillin allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria). Rapid bolus injection of cefotaxime (over &lt;1 minute through a central venous catheter) has been associated with potentially life-threatening arrhythmias.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cefotaxime. Management: Avoid cefotaxime doses greater than 6 g/day with concurrent probenecid.  Any patients receiving this combination should be monitored closely for evidence of cefotaxime toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5951413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Cefotaxime crosses the human placenta and can be found in fetal tissue. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins. During pregnancy, peak cefotaxime serum concentrations are decreased and the serum half-life is shorter. Cefotaxime is approved for use in women undergoing cesarean section (consult current guidelines for appropriate use).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1045978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for signs and symptoms of anaphylaxis during first dose; monitor infusion site for extravasation; with prolonged therapy, monitor renal, hepatic, and hematologic function periodically; number and type of stools/day for diarrhea",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1045969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins; inhibits the final transpeptidation step of peptidoglycan synthesis resulting in cell wall death",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1045984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Into bronchial secretions, middle ear effusions, bone, bile; penetration into CSF when meninges are inflamed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 31% to 50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Partially metabolized in the liver to active metabolite, desacetylcefotaxime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cefotaxime:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Neonates,  birth weight &le;1500 g:  4.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Neonates, birth weight &gt;1500 g: 3.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 1-1.5 hours (prolonged with renal and/or hepatic impairment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Desacetylcefotaxime: 1.5-1.9 hours (prolonged with renal impairment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: I.M.: Within 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (~60% as unchanged drug and metabolites in urine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Moderately dialyzable (20% to 50%)",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1045986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium content of 1 g: 2.2 mEq",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 55, 149.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al, &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2012, 61(31):590-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/22874837/pubmed\" id=\"22874837\" target=\"_blank\">",
"        22874837",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Halperin JJ, Shapiro ED, Logigian E, et al, &ldquo;Practice Parameter: Treatment of Nervous System Lyme Disease (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2007, 69(1):91-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/17522387/pubmed\" id=\"17522387\" target=\"_blank\">",
"        17522387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Solomkin JS, Mazuski JE, Bradley JS, et al, &ldquo;Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      ,  2010, 50(2):133-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/20034345/pubmed\" id=\"20034345\" target=\"_blank\">",
"        20034345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Spritzer R, Kamp HJ, Dzoljic G, et al, &ldquo;Five Years of Cefotaxime Use in a Neonatal Intensive Care Unit,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1990, 9(2):92-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/2179846/pubmed\" id=\"2179846\" target=\"_blank\">",
"        2179846",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, \"Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al, &ldquo;Practice Guidelines for the Management of Bacterial Meningitis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(9):1267-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/15494903/pubmed\" id=\"15494903\" target=\"_blank\">",
"        15494903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Warady BA, Schaefer F, Holloway M, et al, \"Consensus Guidelines for the Treatment of Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis,\"",
"      <i>",
"       Perit Dial Int",
"      </i>",
"      , 2000, 20(6):610-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/11216549/pubmed\" id=\"11216549\" target=\"_blank\">",
"        11216549",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wormser GP, Dattwyler RJ, Shapiro ED, et al, &ldquo;The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2006, 43(9):1089-134.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/23/40310/abstract-text/17029130/pubmed\" id=\"17029130\" target=\"_blank\">",
"        17029130",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13129 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6D34BE7A96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40310=[""].join("\n");
var outline_f39_23_40310=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147493\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147494\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045979\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442224\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045972\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147472\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147456\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045982\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147547\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045976\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045981\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147549\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147546\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045985\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045971\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045970\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298990\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147465\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147468\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5951413\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045978\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045969\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045984\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045986\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13129\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13129|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=related_link\">",
"      Cefotaxime: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/61/34771?source=related_link\">",
"      Cefotaxime: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_23_40311="Wright Giemsa stain morula";
var content_f39_23_40311=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71396%7EHEME%2F60471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71396%7EHEME%2F60471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Wright-Giemsa stain morula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Wright-Giemsa stain of a buffy coat specimen revealed the presence of a morula, or cluster of intracellular coccobacilli, inside of a polymorphonuclear leukocyte (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Donato, AA, Chaudhary, A. Photo Quiz: A 78-Year-Old Man with the \"Summer Flu\" and Cytopenias. Clin Infect Dis 2009; 48:1433. Copyright &copy;2009 University of Chicago Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.journals.uchicago.edu/\">",
"      file://www.journals.uchicago.edu/",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morulae of anaplasmosis in circulating neutrophils",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 294px; height: 656px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 51-year-old man with no significant past medical history presented with a five-day history of fever, malaise, and diffuse myalgias with no recollection of a tick bite. He was found to have thrombocytopenia, elevated transaminase levels, and renal insufficiency. Examination of the peripheral smear suggested the diagnosis of anaplasmosis. He was started on a course of doxycycline with eventual complete resolution of symptoms.",
"    <br>",
"     The peripheral smear (1000x, \"feather edge\") shows morulae of anaplasmosis in the patient's granulocytes. Photomicrographs B and C were taken from the extreme feather edge, and show exploded neutrophils containing well-delineated morulae.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Peripheral smear and patient information kindly provided by Dr. Eddy J Chen and Dr. German Pihan, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Boston, MA.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40311=[""].join("\n");
var outline_f39_23_40311=null;
var title_f39_23_40312="Embryology of AV canal defects";
var content_f39_23_40312=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Embryology of atrioventricular (AV) canal defects",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 520px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram of the embryologic development of the atrioventricular canal region and the spectrum of atrioventricular septal defects (AVSD), including partial, transitional, complete, and intermediate forms. Types A, B, and C refer to the Rastelli classification based on the anatomy of the superior bridging leaflet (please refer to the topic review on the clinical manifestations of atrioventricular canal defects).",
"    <div class=\"footnotes\">",
"     A: anterior leaflet; AB: anterior bridging leaflet; DDCC: dextrodorsal conus cushion; IEC: inferior endocardial cushion; LEC: lateral endocardial cushion; P: posterior leaflet; PB: posterior bridging leaflet; S: septal leaflet; SEC: superior endocardial cushion; L: lateral leaflet.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cetta F, Minich LL, Edwards WD, et al. Atrioventricular septal defects. In: Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult, 7th ed, Allen HD, Shaddy RE, Driscoll DJ, Feltes TF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40312=[""].join("\n");
var outline_f39_23_40312=null;
var title_f39_23_40313="Treatment of Fabry disease";
var content_f39_23_40313=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of Fabry disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Michael Mauer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Jeffrey B Kopp, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/23/40313/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/23/40313/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fabry disease, also called Anderson-Fabry disease, is the second most prevalent lysosomal storage disorder after Gaucher disease. It is an X-linked inborn error of the glycosphingolipid metabolic pathway. This results in accumulation of globotriaosylceramide (Gb3) within lysosomes in a wide variety of cells, thereby leading to the protean manifestations of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no cure for Fabry disease. Treatment with recombinant alpha-galactosidase A (alpha-Gal A), the enzyme that is deficient in patients with Fabry disease, is available and should be considered for eligible individuals, although the impact of enzyme replacement therapy on mortality is unknown.",
"   </p>",
"   <p>",
"    The treatment and prognosis of Fabry disease is presented here. The epidemiology, pathogenesis, clinical manifestations, and diagnosis of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40137?source=see_link\">",
"     \"Clinical features and diagnosis of Fabry disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/45/17111?source=see_link\">",
"     \"Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27414?source=see_link\">",
"     \"Neurologic manifestations of Fabry disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18650162\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-galactosidase A, or alpha-Gal A). All classically affected males (ie, with very low or undetectable levels of alpha-Gal A) should receive enzyme replacement therapy (ERT) as soon as the diagnosis is made, regardless of whether or not clinical manifestations are present. Female carriers and atypically affected males (ie, with marginal levels of alpha-Gal A) should receive ERT if clinical manifestations (eg, renal, neurologic, cardiovascular) are present. We also treat patients who have end-stage renal disease with enzyme replacement, as this may reduce cardiovascular and neurologic complications of Fabry disease. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Use of enzyme replacement therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients who develop chronic kidney disease should receive the same monitoring and care as a patient with chronic kidney disease due to a different etiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37434?source=see_link\">",
"     \"Overview of the management of chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As part of this routine care, we usually treat hypertensive patients who have Fabry disease with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Antihypertensive therapy with a RAS inhibitor'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STUDIES OF ENZYME REPLACEMENT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enzyme replacement therapy (ERT) consists of providing affected patients with the deficient enzyme, alpha-galactosidase A (alpha-Gal A). Two formulations of recombinant human alpha-Gal A have been developed:",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    (Replagal, developed by Transkaryotic Therapies, Cambridge, MA), produced in a genetically engineered human cell line; and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    (Fabrazyme, developed by Genzyme, Cambridge, MA), produced in a Chinese hamster ovary cell line [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/3-6\">",
"     3-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical trials examining the benefits of ERT, as well as the corresponding open-label extensions of those trials, will be reviewed in this section. Recommendations for the use of ERT are discussed below. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Use of enzyme replacement therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3084516\">",
"    <span class=\"h2\">",
"     Summary of trial data",
"    </span>",
"    &nbsp;&mdash;&nbsp;The available data suggest that ERT reduces the neuropathic pain associated with Fabry disease, although beneficial effects on the severity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    progression of other disease manifestations are less clear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/7\">",
"     7",
"    </a>",
"    ]. ERT may reduce tissue deposition of globotriaosylceramide (Gb3) in endothelial cells in the heart, skin, and in most cell types in the kidneys. Notably, ERT clears deposits only minimally from podocytes and only moderately from vascular smooth muscle cells.",
"   </p>",
"   <p>",
"    ERT appears to slow renal function decline in patients who have mild reductions in the glomerular filtration rate (GFR) prior to the initiation of therapy, but may have less benefit when initiated in patients with more advanced renal disease. Larger studies are required to determine whether ERT significantly reduces the risk of stroke, ischemic heart disease, end-stage renal disease (ESRD), or death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     NIH trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a trial conducted by the National Institutes of Health (NIH), 26 affected males were randomly assigned to therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    (Replagal, 0.2",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    infusion every two weeks for 12 doses (24 weeks) or to placebo infusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/5\">",
"     5",
"    </a>",
"    ]. Agalsidase alfa therapy significantly decreased plasma and urine Gb3 levels and improved neuropathic pain (the primary endpoint).",
"   </p>",
"   <p>",
"    Patients in the trial underwent measurement of GFR using inulin clearance, 24-hour urine collection for protein, and protocol kidney biopsies at baseline and 24 weeks. The following effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    on the kidney were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean decline in inulin clearance was smaller with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      compared with placebo (6.2 versus 19.5",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      ), but this did not reach statistical significance. There was no effect of ERT on proteinuria.",
"     </li>",
"     <li>",
"      The number of glomeruli with mesangial widening decreased with ERT and increased with placebo (-12.5 versus +16.5, respectively). Differences in the number of glomeruli with segmental and global sclerosis were not significant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After the six-month intervention period, 25 of the 26 patients entered an open-label extension and received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    therapy for approximately four additional years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/8\">",
"     8",
"    </a>",
"    ]. Patients who had a baseline estimated GFR greater than or equal to 60",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    maintained stable renal function, while renal function declined in those whose baseline estimated GFR was less than 60",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    , although at a slower pace compared with historical controls.",
"   </p>",
"   <p>",
"    Among 11 patients in the open-label extension who demonstrated a continued decline in renal function despite therapy, increasing the frequency of Replagal dosing to once per week appeared to slow the decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/9\">",
"     9",
"    </a>",
"    ]. Prior to the change in dosing, the estimated GFR was 54",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    , and the annual rate of GFR decline was 8.0",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    . At 24 months, after switching to once-per-week dosing, the annual rate of GFR decline had slowed to 3.3",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    .",
"   </p>",
"   <p>",
"    Patients from the NIH trial were analyzed in combination with adult male patients from two other trials which examined the effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/10\">",
"     10",
"    </a>",
"    ]. All 108 patients had serial measurements of GFR using inulin, technetium-DTPA, or chromium-EDTA. The annual rate of GFR decline was nonsignificantly slower in patients receiving agalsidase alfa therapy compared with placebo (4.8 versus 7.0",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ). In the active therapy group, the annual rate of GFR decline was significantly slower in patients with baseline proteinuria less than 1",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    compared with patients whose proteinuria was higher (2.1 versus 6.4",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2373011\">",
"    <span class=\"h2\">",
"     International Fabry Disease Study",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the International Fabry Disease Study, 58 patients (including two females) were randomly assigned to 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    (Fabrazyme) or placebo administered every 2 weeks for 20 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/6\">",
"     6",
"    </a>",
"    ]. Agalsidase beta therapy significantly improved the primary endpoint, defined as the proportion of patients with no Gb3 deposits in renal endothelial cells (69 versus 0 percent). In addition, microvascular endothelial deposition of Gb3 significantly improved in heart and skin tissues of patients receiving active therapy. In contrast, agalsidase beta had no effect on renal function or pain compared with placebo.",
"   </p>",
"   <p>",
"    After 20 weeks, all patients received open-label",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    for an additional six months, at which point protocol kidney biopsies were repeated. ERT cleared Gb3 deposits from glomerular endothelial cells, mesangial cells, and interstitial cells in all patients but had no significant effect on Gb3 deposits in podocytes, distal tubular epithelial cells, and arterial smooth muscle cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients in the study were followed for another four years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Renal disease progression occurred in six patients, all of whom were older than 40 years, had protein excretion greater than 2",
"    <span class=\"nowrap\">",
"     g/24",
"    </span>",
"    hours, and had more than 50 percent glomerular sclerosis at baseline. Renal function remained stable in the other 52 patients. Optional repeat kidney biopsies after four years, performed in eight patients, demonstrated persistently low Gb3 deposition in glomerular endothelial and mesangial cells, but only modest reductions in podocyte and smooth muscle cell deposits. Repeat skin biopsies demonstrated complete clearance of Gb3 from endothelial cells.",
"   </p>",
"   <p>",
"    Infusion reactions were common despite pretreatment with antipyretics and infusion over 2 to 2.5 hours, although the frequency diminished from over 50 to 20 percent or less after 24 months of treatment. Although three patients had to be withdrawn from the study due to positive serum IgE or skin tests, none developed anaphylaxis, and they were later successfully rechallenged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fabry Disease Clinical Trial Study Group",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Fabry Disease Clinical Trial Study Group performed a multicenter trial of 82 adults with Fabry disease who had mild to moderate kidney disease at baseline (mean estimated glomerular filtration rate [eGFR], 53",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ; mean protein excretion, 1.3",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/14\">",
"     14",
"    </a>",
"    ]. Patients were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    (1 mg per kg) or placebo every two weeks for up to 35 months.",
"   </p>",
"   <p>",
"    The primary outcome was the incidence of a major clinical event, defined as one of the following: renal (ESRD or a 33 percent increase in serum creatinine); cardiac (myocardial infarction, arrhythmia, or angina); cerebrovascular (stroke or transient ischemic attack); or death. At a median follow-up of 18.5 months, the following results were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A major clinical event occurred in 13 of 31 patients (42 percent) in the placebo group and 14 of 51 patients (27 percent) in the active therapy group. An increase in the serum creatinine concentration accounted for most of the events.",
"     </li>",
"     <li>",
"      After adjustment for baseline proteinuria, which was higher in patients receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      , active therapy nonsignificantly reduced the risk of having a major clinical event (hazard ratio 0.47, 95% CI 0.21-1.03). Among protocol adherent patients, a similar analysis demonstrated a significant beneficial treatment effect (hazard ratio 0.39, 95% CI 0.16-0.93).",
"     </li>",
"     <li>",
"      The benefits of therapy were larger in patients whose baseline estimated GFR was greater than or equal to 55",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      (hazard ratio 0.19, 95% CI 0.05-0.82) compared with patients whose baseline estimated GFR was less than 55",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      (hazard ratio 0.85, 95% CI 0.32-2.3), although these differences in the effect of ERT were not statistically different from each other.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Studies in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several open-label trials have evaluated the efficacy of ERT in children with Fabry Disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study conducted by the NIH and two other centers examined the safety and efficacy of ERT in 24 children (19 boys, 5 girls, mean age 12 years) with Fabry disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/15,19\">",
"       15,19",
"      </a>",
"      ]. Following six months of therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      (0.2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously every two weeks), plasma Gb3 levels significantly decreased among boys, but not girls, who had normal levels at baseline. Estimated GFR remained stable. There was also a nonsignificant decrease in pain scores, and 6 of 11 patients on medications for neuropathic pain were able to discontinue the drug or reduce the dose. Sweat testing (performed on 13 children) revealed an increase in mean sweat volume, even in those who had anhidrosis. After an open-label extension lasting another 3.5 years, pain severity and heart rate variability were significantly improved compared with baseline.",
"      <br/>",
"      <br/>",
"      Infusion reactions occurred in seven patients (29 percent), but none were severe. Premedication was provided only to patients who experienced an infusion reaction. Only one patient developed IgG antibodies at week nine (none developed IgE antibodies), but this did not appear to influence the course, and antibodies had disappeared by week 17.",
"     </li>",
"     <li>",
"      A four-month trial examined the effect of treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      in 14 male and 2 female patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/17\">",
"       17",
"      </a>",
"      ]. Gb3 levels in dermal capillary endothelium were reduced in all 13 of the patients who had elevated levels prior to treatment. There were also significant reductions in gastrointestinal symptoms, including post-prandial pain and vomiting, and a significant decrease in the mean number of days absent from school because of sickness. Side effects were mild, except for one patient who developed a systemic allergic reaction during infusion and subsequently tested positive for IgE antibodies to agalsidase beta.",
"     </li>",
"     <li>",
"      The effects of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      (0.2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every other week) for at least six months were evaluated in 64 boys and 34 girls in the European Fabry Outcome Survey (FOS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/18\">",
"       18",
"      </a>",
"      ]. Kidney function and left ventricular mass indexed to height remained stable. After 12 and 24 months of therapy, however, the proportion of patients with symptoms did not significantly decline. Treatment-related adverse events were reported in 23 percent of patients, most of which were infusion reactions. Anti-agalsidase alfa IgG antibodies were found in two boys.",
"     </li>",
"     <li>",
"      The long-term renal effects of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      or beta were evaluated in 12 children and young adults (median age, 16 years) with no or minimal renal manifestations who underwent protocol kidney biopsies before and after five years of therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/20\">",
"       20",
"      </a>",
"      ]. Kidney function remained stable throughout the study; in addition, five of the nine patients with elevated urinary albumin excretion had a reduction of albuminuria into the normal range. On subjective histological scoring, Gb3 was completely cleared from glomerular endothelial and mesangial cells, partially cleared from podocytes. In addition, there was an association between this Gb3 reduction in podocytes with both total ERT dose over the five years and reduction in albuminuria.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Studies in patients with end-stage renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited evidence suggests that patients with Fabry disease on dialysis may also benefit from treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. As an example, a study of nine dialysis patients (six hemodialysis and three peritoneal dialysis) who were treated for two years with 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    intravenously every two weeks reported the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate at which the left ventricular mass index increased during the two years on ERT was slowed (by half) compared with the two-year period before the initiation of ERT.",
"     </li>",
"     <li>",
"      Heat intolerance, gastrointestinal symptoms, abdominal pain, pain medication usage, and acroparesthesias improved in most patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, a pilot study in three kidney transplant recipients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    for 18 months reported improvement in pain (in all three patients) and cardiac morphologic abnormalities (in two patients), with no adverse events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/23\">",
"     23",
"    </a>",
"    ]. Another study observed a slower increase in left ventricular mass index in transplanted patients receiving ERT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Adverse events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common side effects with ERT include infusion reactions and seroconversion (ie, the development of antibodies to either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    ). Systemic allergic reactions are rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3084439\">",
"    <span class=\"h3\">",
"     Infusion reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the initial ERT trials, over 60 percent of participants developed rigors, fevers, or other infusion reactions, which tended to diminish over time and were readily controlled with premedication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infusion reactions were less frequent in some later studies of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    and beta (reported to occur in &lt;20 percent), perhaps due to slower infusion rates and the use of pretreatment medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/13,25\">",
"     13,25",
"    </a>",
"    ]. In these later studies, infusion reactions were generally mild and did not preclude resumption of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/25\">",
"     25",
"    </a>",
"    ]. However, in the Fabry Disease Clinical Trial previously described, approximately one-half of patients experienced infusion reactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Fabry Disease Clinical Trial Study Group'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Prevention and treatment of infusion reactions are described below. (See",
"    <a class=\"local\" href=\"#H504640\">",
"     'Prevention and treatment of infusion reactions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3084454\">",
"    <span class=\"h3\">",
"     Seroconversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the trials described above, antibodies to recombinant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    developed in 64 to 88 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/5,6,14\">",
"     5,6,14",
"    </a>",
"    ]. Seroconversion, however, did not limit continued treatment or affect the clinical outcome in these trials. In one of the open-label extension studies, for example, three patients were withdrawn for positive serum IgE or skin tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/13\">",
"     13",
"    </a>",
"    ]. However, all later successfully resumed therapy, and none developed anaphylaxis.",
"   </p>",
"   <p>",
"    In addition, an analysis of 134 adult patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    from various trials suggested that there was",
"    <strong>",
"     no",
"    </strong>",
"    correlation between the production of anti-alpha-Gal A antibodies and clinical events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/26\">",
"     26",
"    </a>",
"    ]. There was, however, a significant association between the antibody titers and Gb3 deposition in the dermal capillary endothelial cells, suggesting that substrate clearance may be impaired in some patients with high antibody titers. Further studies are required to assess the long-term clinical impact of the seroconversion and to determine if those with high antibody titers will require different dosing schedules.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     USE OF ENZYME REPLACEMENT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no studies that definitively guide timing of enzyme replacement therapy (ERT) and duration of therapy once started for either symptomatic or asymptomatic individuals.",
"   </p>",
"   <p>",
"    Treatment is extremely expensive. In 2005, for example, the estimated retail cost of therapy with Fabrazyme for one year was $160,000 in Europe and $206,000 in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Who to treat with ERT and when to begin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uniform recommendations for the use of enzyme replacement therapy (ERT) do not exist. Our recommendations for ERT differ depending upon whether the patient is a classically affected male (ie, with very low or undetectable levels of alpha-galactosidase A [alpha-Gal A]) or a female or a male with an atypical presentation (ie, with marginal levels of alpha-Gal A).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1446782\">",
"    <span class=\"h3\">",
"     Classically affected males",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon the data presented above, we treat all hemizygous males with low or undetectable levels of alpha-Gal A with ERT, whether or not clinical features of Fabry disease are present, and begin therapy as soon as possible after the diagnosis is established. The clinical features and the diagnosis of Fabry disease are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40137?source=see_link\">",
"     \"Clinical features and diagnosis of Fabry disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following observations support the view to initiate \"prophylactic\" therapy in asymptomatic hemizygous males with the classic form of Fabry disease (ie, those with very low or undetectable levels of alpha-Gal A) (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Studies of enzyme replacement therapy'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressive renal disease ultimately develops among all or almost all patients with the classic form of Fabry disease. Globotriaosylceramide (Gb3) accumulation in podocytes begins in childhood and progresses with increasing age. Gb3 accumulation leads first to pathologic abnormalities, such as increasing podocyte foot process width, and subsequently to clinical manifestations, such as proteinuria and reduced glomerular filtration rate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Enzyme replacement is associated with a nonsignificant trend toward clinical benefit, with benefits largely observed in those with preserved renal function at the time ERT is initiated.",
"     </li>",
"     <li>",
"      The benefits of ERT on renal function appear to be limited in patients who already have significant renal impairment when therapy is initiated. The decline in renal function does not always slow and usually does not arrest. This clinical finding is consistent with the pathological observation that ERT does not fully clear Gb3 deposits from podocytes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, we suggest the initiation of ERT in hemizygous males with the classic form of the disease as soon as possible after the diagnosis is established. Our suggestion differs slightly from that made by the European Renal Best Practice (ERBP) group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/28\">",
"     28",
"    </a>",
"    ]. Based upon the reduced benefit from ERT in patients with established renal disease mentioned above, the ERBP suggest that ERT not be initiated in previously untreated patients with proteinuria (greater than 1",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    or reduced glomerular filtration rate (less than 60",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ) unless the patient has other symptoms or signs of Fabry disease that warrant treatment. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1368618298\">",
"    <span class=\"h3\">",
"     Females and males with atypical disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;We treat female carriers and atypically affected males with ERT if clinical manifestations of Fabry disease (eg, renal, neurologic, cardiovascular) are present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/29\">",
"     29",
"    </a>",
"    ]. In addition, we perform a kidney biopsy in such patients and, even if asymptomatic, will treat with ERT if significant Gb3 accumulation is observed. &nbsp;",
"   </p>",
"   <p>",
"    There are several reasons why we do not uniformly treat all asymptomatic females and atypically affected males:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are no rigorous data demonstrating benefit of empiric treatment of such individuals.",
"     </li>",
"     <li>",
"      Not all such individuals with deficient circulating alpha-Gal A activity develop manifestations of the disease; therefore, treatment would be unnecessary.",
"     </li>",
"     <li>",
"      There are no non-invasive biomarkers that reliably predict the risk of serious renal end organ damage in asymptomatic females with Fabry disease.",
"     </li>",
"     <li>",
"      There is a large cost and burden associated with therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H504387\">",
"    <span class=\"h3\">",
"     Patients requiring renal replacement therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients develop end-stage renal disease and require dialysis or kidney transplantation before they are diagnosed with Fabry disease or before ERT is initiated. Such patients should probably receive ERT since they are at high risk for cardiac and cerebrovascular complications.",
"   </p>",
"   <p>",
"    Although data are limited, patients on dialysis appear to derive cardiovascular and neurological benefits from ERT, as noted above. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Studies in patients with end-stage renal disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although recurrence of Fabry disease in a renal allograft might not be expected because cells of the graft have normal alpha-galactosidase A activity, Gb3 accumulation of uncertain functional significance can be seen in renal allograft endothelial cells some years after kidney transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/30\">",
"     30",
"    </a>",
"    ]. These cells are probably of recipient origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/31\">",
"     31",
"    </a>",
"    ], and Gb3 deposits should be cleared by ERT. As with patients on dialysis, ERT may have cardiovascular and neurological benefits in patients who have received a kidney transplant. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Studies in patients with end-stage renal disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dosing of ERT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enzyme replacement doses are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       Agalsidase alfa",
"      </a>",
"      (Replagal) &ndash; 0.2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      as an intravenous infusion every two weeks",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       Agalsidase beta",
"      </a>",
"      (Fabrazyme) &ndash; 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      for as an intravenous infusion every two weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapy is continued indefinitely.",
"   </p>",
"   <p>",
"    One study explored whether a lower dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    (0.3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every two weeks) could maintain the Gb3 clearance that was achieved with the standard dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/32\">",
"     32",
"    </a>",
"    ]. After six months of the standard dose in 21 Fabry patients, Gb3 was cleared from kidney endothelium and skin of all patients. The lower dose was then administered during the subsequent 18 months. Kidney endothelial and skin clearance was maintained in only 70 to 90 percent of patients, suggesting that the lower dose may not be adequate in all patients. In addition, the long-term clinical effects of lower agalsidase doses have not been evaluated. Further studies are required to determine if lower doses can be used in certain patients and how to identify such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H504640\">",
"    <span class=\"h3\">",
"     Prevention and treatment of infusion reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given that infusion reactions occur, patients should receive pretreatment with antipyretics (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    650 mg, 30 minutes prior to infusion), and the enzyme replacement should be given slowly. In the trials presented above,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    was given over 40 minutes, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    was given over a mean of 2 to 2.5 hours (about 10 percent of patients required a slower infusion) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/13,25\">",
"     13,25",
"    </a>",
"    ]. (See",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     \"Agalsidase beta: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the patient develops an infusion reaction, which is usually manifested by fever, tachycardia, rigors hyper- or hypotension, and dyspnea, we proceed in the following way:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stop the infusion.",
"     </li>",
"     <li>",
"      Administer intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      , 0.5 to 1.0",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      not to exceed 50 mg.",
"     </li>",
"     <li>",
"      If the reaction is severe, we also administer intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      , 1 to 2",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      not to exceed 100 mg.",
"     </li>",
"     <li>",
"      If the reaction is slow to resolve, we give a second dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      If the reaction resolves and the patient has normal vital signs, we restart the infusion at a slower rate (usually by 50 to 100 percent of the originally planned infusion duration, eg, 80 minutes for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      and four hours for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients who have had a mild infusion reaction, pretreatment with both",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    should be given prior to subsequent doses. In patients who have had moderate to severe infusion reactions, pretreatment with acetaminophen, diphenhydramine, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    should be given prior to subsequent doses. In addition, all patients with prior infusion reactions should receive ERT more slowly, with durations 50 to 100 percent longer than the duration in patients without infusion reactions.",
"   </p>",
"   <p>",
"    If subsequent infusions are well tolerated, we continue the described pretreatment regimen for six months. Infusion reactions tend to diminish with prolonged administration. Thus, if no subsequent infusion reactions occur, we begin to reduce",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    doses by 25 percent per month. If no complications occur, we then begin to gradually shorten the duration of the infusion.",
"   </p>",
"   <p>",
"    Although the foregoing approach describes our practice in most patients, highly individualized regimens may be required to prevent infusion reactions in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H505528\">",
"    <span class=\"h3\">",
"     Home therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety and feasibility of long-term home infusions was examined in a study of 30 carefully selected patients with Fabry disease in the Netherlands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/33\">",
"     33",
"    </a>",
"    ]. Patients were treated with either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    or beta at a dose of 0.2",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    which they self-administered without medical supervision via a butterfly needle. Only six adverse events (chills or fever) occurred in six patients out of a total of over 1400 infusions. Hypotension or anaphylactoid events were not reported. Those who had a reaction were able to resume therapy with oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    premedication without further adverse events.",
"   </p>",
"   <p>",
"    This low rate of adverse events may be due to the fact that the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"     agalsidase beta",
"    </a>",
"    in this study was substantially lower than in previous studies (0.2 versus 1.0",
"    <span class=\"nowrap\">",
"     mg/kg).",
"    </span>",
"    Home therapy may be a reasonable option, but more data on safety and appropriate patient selection are required before it can be broadly applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Monitoring during therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific guidelines, but patients receiving ERT should have continued monitoring. The extent and timing of evaluations should take into consideration a patient's disease manifestations, disease severity, and side effects of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who are started on ERT prophylactically (ie, asymptomatic patients) should have a clinical evaluation, routine chemistries, and complete blood count every 6 to 12 months. Patients with renal disease should have a similar evaluation plus estimation of the glomerular filtration rate and a urine protein-to-creatinine ratio every three to six months. Patients with cardiac involvement should have an electrocardiogram every 6 to 12 months. In addition, such patients should have an annual echocardiogram during the first two to three years of therapy, repeated thereafter as clinically indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40137?source=see_link\">",
"     \"Clinical features and diagnosis of Fabry disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/45/17111?source=see_link\">",
"     \"Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In asymptomatic female carriers or atypically affected males initiated on ERT because of histologic evidence of disease, we usually repeat the kidney biopsy after three to five years. This scenario is most common in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H505464\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES FOR RENAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Fabry disease are at high risk for progressive kidney failure. Aside from enzyme replacement therapy (ERT), hypertensive patients should receive an inhibitor of the renin-angiotensin system (RAS), such as an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB). In addition, patients should receive standard care for complications of chronic kidney disease, and, when required, dialysis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    transplantation.",
"   </p>",
"   <p>",
"    The short-term and long-term results of renal transplantation for Fabry disease are comparable to transplantation for other causes of end-stage renal disease (ESRD). In contrast, patients with Fabry disease fare worse with maintenance dialysis than other patients with ESRD.",
"   </p>",
"   <p>",
"    As with other causes of ESRD, survival with transplantation is superior to that observed with dialysis. Thus, transplantation should be the treatment of choice for ESRD due to Fabry disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17992?source=see_link&amp;anchor=H11#H11\">",
"     \"Patient survival after renal transplantation\", section on 'Survival compared with Dialysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antihypertensive therapy with a RAS inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are limited on the use of RAS inhibitors in addition to ERT in patients with Fabry disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. As an example, a small series of 11 patients treated with RAS inhibitors suggested that these drugs are associated with a reduction in proteinuria and stabilization of the estimated glomerular filtration rate (eGFR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/35\">",
"     35",
"    </a>",
"    ]. However, a larger study compared the decline in eGFR and proteinuria in 84 patients treated with RAS inhibitors with 124 patients not treated with RAS inhibitors; all patients received ERT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/36\">",
"     36",
"    </a>",
"    ]. After more than five years of follow-up, glomerular filtration rate (GFR) decline and proteinuria were non-significantly worse (not better) in patients treated with RAS inhibitors. Baseline information was not given about those treated and not treated with RAS inhibitors, and it is possible that RAS inhibitors appeared ineffective because the patients who received them had more advanced renal disease at the start. On the other hand, ERT may mitigate the beneficial effects of RAS inhibitors by directly inhibiting the angiotensin-converting enzyme [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treating hypertensive patients with Fabry disease and nephropathy with an ACE inhibitor or an ARB may be a reasonable approach, provided hypotension and significant hyperkalemia can be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/38\">",
"     38",
"    </a>",
"    ], but their superiority over other antihypertensive drugs in such patients is unproven. In addition, the blood pressure goal of",
"    <span class=\"nowrap\">",
"     &lt;130/80",
"    </span>",
"    mmHg is recommended for all such patients with protein excretion exceeding 500 to 1000",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    as it is for patients who have chronic kidney disease due to other etiologies. A somewhat higher goal may be warranted in patients with lower levels of protein excretion. The rationale for these blood pressure goals is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H702990\">",
"    <span class=\"h2\">",
"     Transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidney transplantation for patients with ESRD due to Fabry disease was proposed in the 1970s as an approach that would treat kidney failure and may also correct the metabolic defect by supplying alpha-galactosidase A (alpha-Gal A) from the transplanted kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/39\">",
"     39",
"    </a>",
"    ]. However, there is no evidence that kidney transplantation leads to improvement in any of the clinical manifestations related to other affected organ systems.",
"   </p>",
"   <p>",
"    Conflicting data about graft and patient survival exist comparing patients with Fabry disease with those who have ESRD due to other causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. The two largest studies are summarized here:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study compared 93 patients with ESRD due to Fabry disease transplanted between 1988 and 1998 with a cohort of 186 patients transplanted for ESRD due to other causes, matched for age, race, gender, and length of follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/41\">",
"       41",
"      </a>",
"      ]. Five-year graft survival was similar in patients with and without Fabry disease (67 and 75 percent, respectively). Five- and 10-year patient survival rates were also similar and were comparable with reported rates in the non-diabetic transplant population.",
"     </li>",
"     <li>",
"      A 2009 study compared 197 kidney recipients with Fabry disease to a 10:1 matched cohort of 1970 transplant recipients with other causes of ESRD (matched for age, year of transplant, gender, and other factors) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/42\">",
"       42",
"      </a>",
"      ]. Five-year graft survival (including death with a functioning allograft) was similar in patients with Fabry disease and those in the matched cohort. However, five-year patient survival was worse among patients with Fabry disease (81 versus 90 percent), while return to dialysis was less frequent in patients with Fabry disease (88 versus 80 percent). After adjusting for multiple factors, patients with Fabry disease had a 62 percent higher risk of death compared to recipients with other causes of ESRD. Cardiovascular complications were the leading cause of death in both Fabry and non-Fabry study populations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H702997\">",
"    <span class=\"h3\">",
"     Recurrence of Fabry disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The examination of kidney allograft tissue obtained six and eight months after transplantation has shown Fabry inclusions in the vascular endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/43\">",
"     43",
"    </a>",
"    ]. Another study demonstrated deposition of Gb3 in tubular epithelial and endothelial cells as late as 14 years after transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/44\">",
"     44",
"    </a>",
"    ]. However, these deposits appear to be insufficient to compromise allograft function. It is possible that certain tubular epithelial cells may be unable to process the high systemic load of glycolipid or are of recipient origin and, as mentioned above, that endothelial accumulation may reflect colonization of the graft vascular system by the host endothelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703004\">",
"    <span class=\"h2\">",
"     Dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although survival is lower in Fabry disease patients than in non-Fabry controls, overall survival of patients undergoing maintenance dialysis is relatively good:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 42 patients who initiated dialysis between 1995 and 1997, 64 and 34 percent were treated with hemodialysis and peritoneal dialysis, respectively, with one patient being preemptively transplanted [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/46\">",
"       46",
"      </a>",
"      ]. Three-year survival was slightly lower among these patients compared with non-diabetic end stage renal disease controls (70 and 76 percent, respectively).",
"     </li>",
"     <li>",
"      In a European Renal Association-European Dialysis and Transplant Association report that described patients initiating renal replacement therapy between 1975 and 1993, five-year survival on dialysis was lower among Fabry patients compared with the general dialysis population (41 versus 68 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES FOR PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are scant,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    or other anticonvulsants may be helpful. Non-steroidal anti-inflammatory agents should also be avoided, as these tend to be ineffective and may lead to renal toxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27414?source=see_link\">",
"     \"Neurologic manifestations of Fabry disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372840\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18221192\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survival is greatly reduced in males with classic Fabry disease. Before dialysis was commonly available, such patients usually died in the fourth decade of life, and the availability of dialysis prolonged survival into the fifth decade. None of the patients in the National Institutes of Health (NIH) series mentioned above survived beyond the age of 60 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/48\">",
"     48",
"    </a>",
"    ]. Similar findings were observed in a study from England [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/49\">",
"     49",
"    </a>",
"    ]. Median cumulative survival was 50 years, with very few individuals alive after the age of 60 years. Most deaths are due to cardiovascular disease (including stroke, myocardial infarction, and heart failure), although deaths from renal failure, sepsis, and suicide have also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2374302\">",
"    <span class=\"h2\">",
"     Other long term outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A report from the Fabry Outcome Survey, a European outcomes database established to track the natural history and response to treatment of Fabry disease, provided information on the effects of enzyme replacement on cardiac, kidney, and pain outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/25,36\">",
"     25,36",
"    </a>",
"    ]. There were 545 patients from 11 countries; 314 had received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    for at least one (60 percent) or two (29 percent) years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/25\">",
"     25",
"    </a>",
"    ]. Long-term (ie, five years or more) outcomes on kidney function were available in 208 patients who received enzyme replacement therapy (ERT) for a mean of 7.4 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following findings were noted in adults:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Through at least five years of follow-up, estimated glomerular filtration rate (eGFR) declined by 2.2",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      in hemizygous males and by 0.7",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      in females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/36\">",
"       36",
"      </a>",
"      ]. Estimated glomerular filtration rate decline was faster in patients who had proteinuria or hypertension at the time",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      was initiated. The results were similar in patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among those who had echocardiographic follow-up (28 and 18 percent after one and two years, respectively), mean ventricular wall thickness and left ventricular mass decreased significantly.",
"     </li>",
"     <li>",
"      Some measures of pain and interference of pain with daily activities (determined with the Brief Pain Inventory questionnaire) were improved at one year, but not all were sustained at two years; however, there was a sustained improvement in quality of life at one and two years (mean score of the European Quality of Life Questionnaire improved from 0.5 to 0.7, p&lt;0.05).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar findings were reported in a smaller study of 26 patients who received a mean of two years of enzyme replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/51\">",
"     51",
"    </a>",
"    ]. Kidney function was stable in most patients. Three patients with glomerular filtration rate (GFR) &lt;25",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    at baseline progressed to end-stage renal disease within six months, and two patients died. Another study analyzing data from 165 adult Fabry patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    for three years suggested that the ERT may slow the decline in renal function, even in those with eGFR &le;59",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children, the best prognostic data come from an analysis of 64 boys and 34 girls in the Fabry Outcome Survey who were treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"     agalsidase alfa",
"    </a>",
"    (0.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every other week) for at least six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/23/40313/abstract/18\">",
"     18",
"    </a>",
"    ]. Kidney function and left ventricular mass indexed to height remained stable. However, the prevalence of symptoms was not significantly reduced after 12 and 24 months of ERT. Fifty-eight treatment-related adverse events were reported in 23 patients (21 boys and 2 girls), including 55 infusion reactions. Anti-agalsidase alfa IgG antibodies were found in two boys.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H404833\">",
"    <span class=\"h2\">",
"     Background",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fabry disease is an X-linked lysosomal storage disorder that results in accumulation of globotriaosylceramide (Gb3) within lysosomes in a wide variety of cells, thereby leading to the protean manifestations of the disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The available data suggest that enzyme replacement therapy (ERT, either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      ) may reduce the severity",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progression of disease manifestations. Overall, ERT effectively reduces tissue deposition of Gb3 in the heart, skin, and in most cell types in the kidneys (with the notable exception that ERT clears deposits only minimally from podocytes and modestly from vascular smooth muscle). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Studies of enzyme replacement therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ERT may slow renal function decline in patients who have mild reductions in glomerular filtration rate (GFR) prior to the initiation of therapy, but may have less benefit when initiated in patients with more advanced renal functional decline and proteinuria. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Studies of enzyme replacement therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common side effects with ERT include infusion reactions and seroconversion (ie, the development of antibodies to either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      ). Systemic allergic reactions are rare. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Adverse events'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H404825\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among classically affected males (ie, males with very low or undetectable levels of alpha-galactosidase A [alpha-Gal A]) who have renal manifestations, we recommend ERT, ideally as soon as such manifestations are observed (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1446782\">",
"       'Classically affected males'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among classically affected males with Fabry disease who are asymptomatic, we suggest enzyme replacement therapy as soon as possible following diagnosis (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1446782\">",
"       'Classically affected males'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients who have end-stage renal disease due to Fabry disease (including those who have had a kidney transplant), we suggest ERT with the goal of reducing the consequences of other organ involvement (eg, cardiac, neurologic) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H504387\">",
"       'Patients requiring renal replacement therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients with Fabry disease who have substantial non-renal manifestations, we suggest initiating ERT, ideally as soon as such manifestations are observed (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1368618298\">",
"       'Females and males with atypical disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among asymptomatic female carriers or males with atypical presentations (ie, with marginal levels of alpha-Gal A), we suggest ERT on a case-by-case basis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ), given the uncertain benefit and high cost and burden of therapy. (See",
"      <a class=\"local\" href=\"#H1368618298\">",
"       'Females and males with atypical disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients selected for ERT, enzyme replacement doses are as follows (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Dosing of ERT'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       Agalsidase alfa",
"      </a>",
"      (Replagal) &ndash; 0.2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      as an intravenous infusion every two weeks",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       Agalsidase beta",
"      </a>",
"      (Fabrazyme) &ndash; 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      for as an intravenous infusion every two weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Once initiated, ERT is continued indefinitely. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Dosing of ERT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given that infusion reactions occur, patients should receive pretreatment with antipyretics (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      650 mg, 30 minutes prior to infusion), and the enzyme replacement should be given slowly (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38867?source=see_link\">",
"       agalsidase alfa",
"      </a>",
"      over 40 minutes and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=see_link\">",
"       agalsidase beta",
"      </a>",
"      over 2 to 2.5 hours). Management of infusion reactions typically involves temporarily stopping the infusion,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      , glucocorticoids, and resuming the infusion at a slower rate. (See",
"      <a class=\"local\" href=\"#H504640\">",
"       'Prevention and treatment of infusion reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are started on ERT prophylactically (ie, asymptomatic patients) should have a clinical evaluation, routine chemistries, and complete blood count every 6 to 12 months. Patients with renal disease should have a similar evaluation plus estimation of the glomerular filtration rate and a urine protein-to-creatinine ratio every three to six months. Patients with cardiac involvement should have an electrocardiogram every 6 to 12 months. In addition, such patients should have an annual echocardiogram during the first two to three years of therapy, repeated thereafter as clinically indicated. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Monitoring during therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar to other patients with chronic kidney disease, we treat hypertensive patients with Fabry disease with an inhibitor of the renin-angiotensin system, such as an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. In addition, we offer standard care for complications of chronic kidney disease, and, when required, dialysis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    transplantation. As with other causes of end-stage renal disease (ESRD), survival with transplantation is superior to that observed with dialysis. Thus, transplantation should be the treatment of choice for ESRD due to Fabry disease. The short-term and long-term results of kidney transplantation for Fabry disease are comparable to transplantation for other causes of ESRD. (See",
"    <a class=\"local\" href=\"#H505464\">",
"     'Other therapies for renal disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors would like to acknowledge Drs. Monique Cho and Raphael Schiffmann, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/1\">",
"      Germain DP. Fabry disease. Orphanet J Rare Dis 2010; 5:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/2\">",
"      Lidove O, Kaminsky P, Hachulla E, et al. Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet 2012; 81:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/3\">",
"      Schiffmann R, Murray GJ, Treco D, et al. Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A 2000; 97:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/4\">",
"      Eng CM, Banikazemi M, Gordon RE, et al. A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 2001; 68:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/5\">",
"      Schiffmann R, Kopp JB, Austin HA 3rd, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285:2743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/6\">",
"      Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A--replacement therapy in Fabry's disease. N Engl J Med 2001; 345:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/7\">",
"      El Dib RP, Nascimento P, Pastores GM. Enzyme replacement therapy for Anderson-Fabry disease. Cochrane Database Syst Rev 2013; 2:CD006663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/8\">",
"      Schiffmann R, Ries M, Timmons M, et al. Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting. Nephrol Dial Transplant 2006; 21:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/9\">",
"      Schiffmann R, Askari H, Timmons M, et al. Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing. J Am Soc Nephrol 2007; 18:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/10\">",
"      West M, Nicholls K, Mehta A, et al. Agalsidase alfa and kidney dysfunction in Fabry disease. J Am Soc Nephrol 2009; 20:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/11\">",
"      Thurberg BL, Rennke H, Colvin RB, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 2002; 62:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/12\">",
"      Germain DP, Waldek S, Banikazemi M, et al. Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 2007; 18:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/13\">",
"      Wilcox WR, Banikazemi M, Guffon N, et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 2004; 75:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/14\">",
"      Banikazemi M, Bultas J, Waldek S, et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med 2007; 146:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/15\">",
"      Ries M, Clarke JT, Whybra C, et al. Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 2006; 118:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/16\">",
"      Ramaswami U, Wendt S, Pintos-Morell G, et al. Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta Paediatr 2007; 96:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/17\">",
"      Wraith JE, Tylki-Szymanska A, Guffon N, et al. Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr 2008; 152:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/18\">",
"      Ramaswami U, Parini R, Pintos-Morell G, et al. Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey. Clin Genet 2012; 81:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/19\">",
"      Schiffmann R, Martin RA, Reimschisel T, et al. Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease. J Pediatr 2010; 156:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/20\">",
"      T&oslash;ndel C, Bostad L, Larsen KK, et al. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol 2013; 24:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/21\">",
"      Pisani A, Spinelli L, Sabbatini M, et al. Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. Am J Kidney Dis 2005; 46:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/22\">",
"      Pastores GM, Boyd E, Crandall K, et al. Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease. Nephrol Dial Transplant 2007; 22:1920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/23\">",
"      Mignani R, Panichi V, Giudicissi A, et al. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study. Kidney Int 2004; 65:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/24\">",
"      Mignani R, Feriozzi S, Pisani A, et al. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant 2008; 23:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/25\">",
"      Beck M, Ricci R, Widmer U, et al. Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 2004; 34:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/26\">",
"      B&eacute;nichou B, Goyal S, Sung C, et al. A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease. Mol Genet Metab 2009; 96:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/27\">",
"      Najafian B, Svarstad E, Bostad L, et al. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int 2011; 79:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/28\">",
"      Terryn W, Cochat P, Froissart R, et al. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrol Dial Transplant 2013; 28:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/29\">",
"      Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/30\">",
"      Mosnier JF, Degott C, Bedrossian J, et al. Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 1991; 51:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/31\">",
"      Bai HW, Shi BY, Qian YY, et al. Endothelial cell chimerism by fluorescence in situ hybridization in gender mismatched renal allograft biopsies. Chin Med J (Engl) 2007; 120:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/32\">",
"      Lubanda JC, Anijalg E, Bzd&uacute;ch V, et al. Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease. Genet Med 2009; 11:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/33\">",
"      Linthorst GE, Vedder AC, Ormel EE, et al. Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands. Nephrol Dial Transplant 2006; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/34\">",
"      Weidemann F, Sommer C, Duning T, et al. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med 2010; 123:658.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/35\">",
"      Tahir H, Jackson LL, Warnock DG. Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta. J Am Soc Nephrol 2007; 18:2609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/36\">",
"      Feriozzi S, Torras J, Cybulla M, et al. The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy. Clin J Am Soc Nephrol 2012; 7:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/37\">",
"      Batista EC, Carvalho LR, Casarini DE, et al. ACE activity is modulated by the enzyme &alpha;-galactosidase A. J Mol Med (Berl) 2011; 89:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/38\">",
"      Wanner C, Breunig F. Fabry nephropathy and the case for adjunctive renal therapy. J Am Soc Nephrol 2007; 18:2426.",
"     </a>",
"    </li>",
"    <li>",
"     Desnick R, Ioannou Y, Eng C.. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, et al (Eds), McGraw Hill, New York City 2001. p.3733.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/40\">",
"      Maizel SE, Simmons RL, Kjellstrand C, Fryd DS. Ten-year experience in renal transplantation for Fabry's disease. Transplant Proc 1981; 13:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/41\">",
"      Ojo A, Meier-Kriesche HU, Friedman G, et al. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 2000; 69:2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/42\">",
"      Shah T, Gill J, Malhotra N, et al. Kidney transplant outcomes in patients with Fabry disease. Transplantation 2009; 87:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/43\">",
"      Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002; 13 Suppl 2:S134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/44\">",
"      Gantenbein H, Bruder E, Burger HR, et al. Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant 1995; 10:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/45\">",
"      Peces R. Is there true recurrence of Fabry's disease in the transplanted kidney? Nephrol Dial Transplant 1996; 11:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/46\">",
"      Thadhani R, Wolf M, West ML, et al. Patients with Fabry disease on dialysis in the United States. Kidney Int 2002; 61:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/47\">",
"      Tsakiris D, Simpson HK, Jones EH, et al. Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 1996; 11 Suppl 7:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/48\">",
"      Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/49\">",
"      MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/50\">",
"      Warnock DG, Ortiz A, Mauer M, et al. Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant 2012; 27:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/51\">",
"      Breunig F, Weidemann F, Strotmann J, et al. Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 2006; 69:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/23/40313/abstract/52\">",
"      Feriozzi S, Schwarting A, Sunder-Plassmann G, et al. Agalsidase alfa slows the decline in renal function in patients with Fabry disease. Am J Nephrol 2009; 29:353.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7207 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-298F256B3B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40313=[""].join("\n");
var outline_f39_23_40313=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18650162\">",
"      GENERAL APPROACH TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STUDIES OF ENZYME REPLACEMENT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3084516\">",
"      Summary of trial data",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NIH trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2373011\">",
"      International Fabry Disease Study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fabry Disease Clinical Trial Study Group",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Studies in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Studies in patients with end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Adverse events",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3084439\">",
"      - Infusion reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3084454\">",
"      - Seroconversion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      USE OF ENZYME REPLACEMENT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Who to treat with ERT and when to begin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1446782\">",
"      - Classically affected males",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1368618298\">",
"      - Females and males with atypical disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H504387\">",
"      - Patients requiring renal replacement therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dosing of ERT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H504640\">",
"      - Prevention and treatment of infusion reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H505528\">",
"      - Home therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Monitoring during therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H505464\">",
"      OTHER THERAPIES FOR RENAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antihypertensive therapy with a RAS inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H702990\">",
"      Transplantation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H702997\">",
"      - Recurrence of Fabry disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H703004\">",
"      Dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OTHER THERAPIES FOR PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2372840\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18221192\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2374302\">",
"      Other long term outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H404833\">",
"      Background",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H404825\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?8/34/8741?source=related_link\">",
"      Agalsidase beta: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/45/17111?source=related_link\">",
"      Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40137?source=related_link\">",
"      Clinical features and diagnosis of Fabry disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27414?source=related_link\">",
"      Neurologic manifestations of Fabry disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37434?source=related_link\">",
"      Overview of the management of chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17992?source=related_link\">",
"      Patient survival after renal transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_23_40314="Glomus tumor nail dystrophy";
var content_f39_23_40314=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51899%7EDERM%2F61115%7EDERM%2F72924%7EDERM%2F81221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51899%7EDERM%2F61115%7EDERM%2F72924%7EDERM%2F81221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor with nail dystrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nail dystrophy caused by a subungual glomus tumor. The red subungual patch indicates the location of the tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left: Red flush of the nail bed induced by a subungual glomus tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bluish-red flush of the nail induced by a glomus tumor of the nail bed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pilomatricoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A firm blue-gray papule is present on the cheek of this 12-year-old girl.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40314=[""].join("\n");
var outline_f39_23_40314=null;
var title_f39_23_40315="ASCUS triage based on age";
var content_f39_23_40315=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Performance of HPV DNA testing versus repeat thin layer cytology in triage of women with ASCUS for colposcopic evaluation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Triage strategy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity for detection of CIN3 or higher, percent (95 percent CI)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Women referred for colposcopy, percent (95 percent CI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Age 23 to 28 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV testing",
"       </td>",
"       <td>",
"        96 (91 to 100)",
"       </td>",
"       <td>",
"        65 (62 to 69)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat cytology for ASCUS",
"       </td>",
"       <td>",
"        88 (79 to 97)",
"       </td>",
"       <td>",
"        64 (60 to 68)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Age &ge;29 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV testing",
"       </td>",
"       <td>",
"        94 (86 to 100)",
"       </td>",
"       <td>",
"        31 (28 to 34)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat cytology for ASCUS",
"       </td>",
"       <td>",
"        91 (81 to 100)",
"       </td>",
"       <td>",
"        50 (47 to 54)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        All ages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV testing",
"       </td>",
"       <td>",
"        96 (93 to 100)",
"       </td>",
"       <td>",
"        54 (52 to 56)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat cytology for ASCUS",
"       </td>",
"       <td>",
"        86 (80 to 92)",
"       </td>",
"       <td>",
"        59 (57 to 61)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     CI: confidence interval; ASCUS: atypical squamous cells of unknown significance.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Sherman ME, Schiffman M, Cox JT. J Natl Cancer Inst 2002; 94:102.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40315=[""].join("\n");
var outline_f39_23_40315=null;
var title_f39_23_40316="Assisting patients with smoking cessation";
var content_f39_23_40316=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Assisting patients with smoking cessation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Strategies for implementation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Help the patient with a quit plan",
"       </td>",
"       <td>",
"        Set a quit date. Ideally, the quit date should be within 2 weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tell family, friends, and coworkers about quitting and request understanding and support.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticipate challenges to planned quit attempt, particularly during the critical first few weeks. These include nicotine withdrawal symptoms.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove tobacco products from your environment. Prior to quitting, avoid smoking in places where you spend a lot of time (eg, work, home, car).",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Provide practical counseling (problem solving/training)",
"       </td>",
"       <td>",
"        Abstinence - Total abstinence is essential. \"Not even a single puff after the quit date.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Past quit experience - Review past quit attempts including identification of what helped during the quit attempt and what factors contributed to relapse.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticipate triggers or challenges in upcoming attempt - Discuss challenges/triggers and how patient will successfully overcome them. Advise patient to remove all tobacco from home, car, and work environment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol - Because alcohol can cause relapse, the patient should consider limiting/abstaining from alcohol while quitting.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other smokers in the household - Quitting is more difficult when there is another smoker in the household. Patients should encourage housemates to quit with them or not smoke in their presence.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Provide intra-treatment social support",
"       </td>",
"       <td>",
"        Provide a supportive clinical environment while encouraging the patient in his or her quit attempt. \"My office staff and I are available to assist you.\"",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Help the patient obtain extra-treatment social support",
"       </td>",
"       <td>",
"        Help the patient develop social support for his or her quit attempt in his or her environments outside of treatment. \"Ask your spouse/partner, friends, and coworkers to support you in your quit attempt.\"",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Recommend the use of approved pharmacotherapy, except in special circumstances",
"       </td>",
"       <td>",
"        Recommend the use of pharmacotherapies found to be effective. Explain how these medications increase smoking cessation success and reduce withdrawal symptoms.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Provide supplementary materials",
"       </td>",
"       <td>",
"        Sources - Federal agencies, nonprofit agencies, or local/state health departments. Offer a free telephone quitline (In the US, 1-800-QUIT-NOW or 1-800-784-8669 can be used).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type - Culturally/racially/educationally/age appropriate for the patient.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Location - Readily available at every clinician's workstation.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Fiore MC, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. 2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40316=[""].join("\n");
var outline_f39_23_40316=null;
var title_f39_23_40317="Scintigraphic gastric emptying assessment";
var content_f39_23_40317=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F69354&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F69354&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Scintigraphic gastric emptying assessment in gastric stasis and gastric dumping",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 185px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scintigraphic study in gastric stasis (left panel) and gastric dumping (right panel) at&nbsp;two and&nbsp;four hours; the blue hatched lines at two and four hours refer to normal gastric retention. Compared with normals, the tracer is removed more slowly at&nbsp;two and four hours with gastric stasis, and more rapidly at two hours with gastric dumping.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Thomforde GM, Camilleri M, Phillips SF, et al. J Nucl Med 1995; 36:93.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40317=[""].join("\n");
var outline_f39_23_40317=null;
var title_f39_23_40318="Contents: Calcium phosphate magnesium";
var content_f39_23_40318=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Calcium phosphate magnesium",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Calcium phosphate magnesium",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Calcium balance",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/36/2631\">",
"           Chapter 6F: Hormonal regulation of calcium and phosphate balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/39/19061\">",
"           Diuretics and calcium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9462\">",
"           Metabolism of vitamin D",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/3/39990\">",
"           Overview of vitamin D",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/56/36744\">",
"           Parathyroid hormone secretion and action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypercalcemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/56/33669\">",
"           Clinical manifestations of hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/19/1338\">",
"           Clinical manifestations of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/26/5545\">",
"           Diagnosis and differential diagnosis of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/28/20934\">",
"           Diagnostic approach to hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19258\">",
"           Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/22/28007\">",
"           Etiology of hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/16/2310\">",
"           Hypercalcemia in granulomatous diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/48/41734\">",
"           Hypercalcemia of malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/47/8954\">",
"           Management of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/8/40073\">",
"           Parathyroid and mineral metabolism after renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/58/21416\">",
"           Parathyroid hormone assays and their clinical use",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30361\">",
"           Pathogenesis and etiology of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/60/18377\">",
"           Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/29/27094\">",
"           The milk-alkali syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/42/16041\">",
"           Treatment of hypercalcemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypermagnesemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/58/13220\">",
"           Causes and treatment of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/9/32914\">",
"           Symptoms of hypermagnesemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperphosphatemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/12/26822\">",
"           Chapter 6G: Calcium and phosphate metabolism in renal failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/13/13527\">",
"           Overview of the causes and treatment of hyperphosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/57/33690\">",
"           Treatment of hyperphosphatemia in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/1/19481\">",
"           Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/20/3402\">",
"           Tumor lysis syndrome: Prevention and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypocalcemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/18/38184\">",
"           Causes of vitamin D deficiency and resistance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/50/36646\">",
"           Clinical manifestations of hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/13/34005\">",
"           Diagnostic approach to hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19258\">",
"           Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/25/24984\">",
"           Etiology of hypocalcemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/13/3287\">",
"           Hungry bone syndrome following parathyroidectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/58/21416\">",
"           Parathyroid hormone assays and their clinical use",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/37/44632\">",
"           Treatment of hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/21/3417\">",
"           Treatment of vitamin D deficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/1/19481\">",
"           Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/20/3402\">",
"           Tumor lysis syndrome: Prevention and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypomagnesemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/41/15000\">",
"           Causes of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/63/11254\">",
"           Evaluation and treatment of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/13/3287\">",
"           Hungry bone syndrome following parathyroidectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/45/16085\">",
"           Significance of hypomagnesemia in cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/37/42580\">",
"           Signs and symptoms of magnesium depletion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypophosphatemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/25/15767\">",
"           Causes of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2167\">",
"           Diagnosis and treatment of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21209\">",
"           Hereditary hypophosphatemic rickets and tumor-induced osteomalacia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/13/3287\">",
"           Hungry bone syndrome following parathyroidectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/42/28324\">",
"           Hypophosphatemia in the alcoholic patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/8/40073\">",
"           Parathyroid and mineral metabolism after renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/57/32659\">",
"           Signs and symptoms of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/21/3417\">",
"           Treatment of vitamin D deficiency in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Magnesium balance",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/41/43668\">",
"           Diuretics and magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Phosphate balance",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/12/26822\">",
"           Chapter 6G: Calcium and phosphate metabolism in renal failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9462\">",
"           Metabolism of vitamin D",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/3/39990\">",
"           Overview of vitamin D",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-BB1942CC6E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f39_23_40318=[""].join("\n");
var outline_f39_23_40318=null;
var title_f39_23_40319="Endoscopic treatment bleeding diverticulum";
var content_f39_23_40319=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Treatment of a bleeding colonic diverticulum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 164px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An oozing visible vessel (arrow) can be seen at the mouth of a sigmoid diverticulum (arrowhead, Panel A). The vessel was treated with combination endoscopic therapy using epinephrine injection (1:10,000 dilution) followed by Gold probe electrocautery (Panel B). The area was then tattooed with India ink for easy identification in the event of rebleeding or the need for surgery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rome Jutabha, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_23_40319=[""].join("\n");
var outline_f39_23_40319=null;
